Fisetinidol-(4alpha->6\')-peltogynan-4alpha-ol



Compound IDCDAMM02004
Common nameFisetinidol-(4alpha->6\')-peltogynan-4alpha-ol
IUPAC name1-[2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2H-chromen-4-yl]-5,6a,7,12a-tetrahydroisochromeno[4,3-b]chromene-2,3,7,10-tetrol
Molecular formulaC31H26O11

Experimental data

Retention time11.63
Adduct[M+H]+
Actual mz575.159
Theoretical mz575.155
Error7.17
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.0115

Identifiers and class information

Inchi keyRFCUPSAXFIFCRB-OJRFXIPHNA-N
SmilesOC1=CC=C2C(OC3C=4C(=CC(O)=C(O)C4C5C6=CC=C(O)C=C6OC(C7=CC=C(O)C(O)=C7)C5O)COC3C2O)=C1
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)6
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)574.54
Computed dipole moment(dipole)6.433
Total solvent accessible surface area (SASA)841.474
Hydrophobic component of SASA (FOSA)98.07
Hydrophilic component of SASA (FISA)365.842
Pie component of the SASA (PISA)377.562
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1575.6
Number of hydrogen bond donors (donorHB)8
Number of hydrogen bond acceptors (accptHB)11.1
Free energy of solvation of dipole (dip^2/V)0.0262646
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0373102
Globularity descriptor (glob)0.778196
Predicted polarizability in cubic angstroms (QPpolrz)55.371
Predicted hexadecane/gas partition coefficient (QPlogPC16)20.044
Predicted octanol/gas partition coefficient (QPlogPoct)37.741
Predicted water/gas partition coefficient (QPlogPw)27.687
Predicted octanol/water partition coefficient (QPlogPo/w)1.335
Predicted aqueous solubility (QPlogS)-5.565
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.402
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.922
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)3.362
Predicted brain/blood partition coefficient (QPlogBB)-3.946
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.049
Predicted skin permeability, log Kp (QPlogKp)-6.164
PM3 calculated ionization potential (IP(ev))8.83
PM3 calculated electron affinity (EA(eV))0.232
Number of likely metabolic reactions (#metab)14
Prediction of binding to human serum albumin (QPlogKhsa)0.023
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)5.31
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)188.862
Number of nitrogen and oxygen atoms (#NandO)11
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P49763PGFPlacenta growth factorT70792SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD

Copyright © 2025